Home

Microbes in the human body

According to a recent National Institutes of Health (NIH) estimate, 90% of cells in the human body are bacterial, fungal, or otherwise non-human.1) Although many have concluded that bacteria surely enjoy a commensal relationship with their human hosts, only a fraction of the human microbiotaThe bacterial community in the human body. Many species in the microbiota contribute to the development of chronic disease. has been characterized, much less identified. The sheer number of non-human genes represented by the human microbiota – there are millions in our “extended genome”2) compared to the nearly 23,000 in the human genome – implies we have just begun to fathom the full extent to which bacteria work to facilitate their own survival. 3)

The NIH's ongoing initiative, the Human MicrobiomeThe bacterial community in the human body. Many species in the microbiota contribute to the development of chronic disease. Project, aspires to catalog the human microbiome, also referred to as the human metagenome. Emerging insights from environmental sampling studies have shown, for example, that in vitroA technique of performing a given procedure in a controlled environment outside of a living organism - usually a laboratory. based methods for culturing bacteria have drastically underrepresented the size and diversity of bacterial populations. One environmental sample of human hands found 100 times more species than had previously been detected using purely culture-based methods. Another study which also employed high throughput genomic sequencing discovered high numbers of hydrothermal vent eubacteria on prosthetic hip joints, a species once thought only to persist in the depths of the ocean.

Human microbiota

Recent research has demonstrated that the diversity, prevalence and persistence of bacteria has been consistently underestimated. Microbes form most of the world's biomass: there are typically 40 million bacterial cells in a gram of soil and a million bacterial cells in a milliliter (gram) of fresh water.4) Studies have found bacteria in areas previously thought to be completely sterile. A broad diversity of bacteria were found at all of the “clean rooms” where NASA spacecraft are assembled and in spite of the highly desiccated, nutrient-bare conditions within.5)

Bacteria are no less persistent or proliferative inside the human body.

One prominent researcher called human skin a “virtual zoo of bacteria.”6) Another compared the diversity in the human gut to a rain forest.7) The human gut alone contains on average: 40,000 bacterial species,8) 9 million unique bacterial genes and 100 trillion microbial cells.9) According to Asher Mullard, “Between them [the bacteria in our bodies], they harbor millions of genes, compared with the paltry 20,000 estimated in the human genome. To say that you are outnumbered is a massive understatement.”10)

The global initiative known as the Human Microbiome Project currently estimates that the microorganisms that live inside or on Homo sapiens outnumber somatic (body) and germ cells [germ cells as in gametes, not bacteria] by a factor of ten.11) To this point, only approximately 1% of this microbiotaThe bacterial community which causes chronic diseases - one which almost certainly includes multiple species and bacterial forms. has been characterized and identified.12) The Human Microbiome Project aims to catalog the balance using an array of molecular sequencing techniques over the coming years.13) The combined genetic contributions of these microbes — in excess of 1,000,000 protein-coding genes — provide traits not encoded in our own genomes.14)

Since the inception of the Human Microbiome Project in 2007, dozens of research teams have gathered data which redefine what it means to be human. Some commentators have gone so far as to refer to the human body as a superorganism whose “whose metabolism represents an amalgamation of microbial and human attributes.”15)

Genes in the human microbiota far outnumber those in the human genome.

Insights from new molecular methods for identifying bacteria

Related article: Detecting bacteria

Researchers have long known that traditional methods for identifying bacteria are effective at identifying only a fraction of the bacteria in a given sample. New genomic based methods such as polymerase chain reaction (PCR) detect bacterial forms based on the presence of bacterial DNA or RNA. These new techniques are leading to some unexpected insights about bacteria.

  • Bacteria are everywhere including the world's most hostile environments – According to Penn State researcher Jennifer Loveland-Curtze, “Microbes comprise up to one-third or more of the Earth’s biomass, yet fewer than 8,000 microbes have been described out of the approximately 3,000,000 that are presumed to exist,”
    • NASA “clean rooms” – One would think that the the one place on Earth where bacteria do not exist is in the NASA “clean rooms” – the supposedly sterile places used to assemble aircraft. A 2007 research team compared the prevalence of bacteria found using traditional culture-based methods and ribosomal RNA gene sequence analysis. The four geographically diverse samples taken show a broad diversity in the types of bacteria able to grow in the most hostile environments including almost 100 types of bacteria, about 45 percent of which were previously unknown to science.16) The findings were something of a shock for NASA, an agency now forced to wonder exactly how many unknown pathogens have been taken to the moon and Mars.
    • Two miles below the surface of a Greenland glacier – A Penn State team found viable “ultrasmall bacteria” in a glacial core17) – a habitat which is low-temperature, high-pressure, reduced-oxygen, and nutrient-poor. The core was estimated to be 120,000 years old.
    • Deepest layer of the earth's crust – A 2010 analysis of the deepest layer of the Earth's oceanic crust has revealed a new ecosystem living over a kilometer beneath our feet. It is the first time that life has been found in the crust's deepest layer.18)
Intrapersonal and interpersonal variability of the human microbiome is profound. A 2012 study of the human vaginal microbiome found profound shifts over time and between subjects. Red bars indicate menses.
  • In tissue sites once deemed sterile – The Relman Lab at Stanford used real time PCR to target conserved regions of the bacterial 16S ribosomal DNA (rDNA). They concluded that there is a substantial and “normal” population of bacterial DNA sequences in the blood of even healthy individuals.19)
  • Antibiotic resistant strains predate human discovery of antibiotics – In a 2011 Nature study (press release), researchers carefully dug ancient 30,000 year old permafrost sediments out of the Canadian Northwest and sequenced the bacterial DNA found in it.20) The team concluded that antibiotic resistance genes predate our use of antibiotics and offers the first direct evidence that antibiotic resistance is an ancient, naturally occurring phenomenon widespread in the environment. This should not be surprising especially when one considers that penicillin came from a mold, tetracycline and demeclocycline from a strep mutant while Vancomycin came from Amycolatopsis orientalis.
  • Each person has a unique mix of pathogens – A study led by Dr. Noah Fierer used a high-throughput method for PCR testing to identify the number and species of bacteria present on the hands of 51 undergraduate students leaving an exam room. Each student whose bacterial “fingerprint” – that is, their unique combination of bacteria – was sequenced, carried on average 3,200 bacteria from 150 species on their hands. Only five species were found on all the students’ hands, while any two hands – even belonging to the same person – had only 13% of their bacterial species in common.21)
  • Communities of people have distinctive mixes of microbes – Two human ethnic groups based in India, which could not be distinguished on the basis of human DNA markers, could be distinguished based on their patterns of H. pylori variation.22)
  • Communities of microbes associated with a disease may be more diverse than controlsasthma,23) bacterial vaginosis24)
  • Communities of microbes associated with a disease may be less diverse than controlsirritable bowel syndrome,25) Crohn's disease,26) type I diabetes,27)AIDS28)
  • Microbial variability may be relatively unrelated to food intake – While Dumas has shown that there are significant inter-regional differences in metabolites,29) work on the oral microbiome implies this may not be due to food consumption. In studying the oral microbiome, Nasidzie et al. took saliva samples from people in twelve diverse regions throughout the world including China, Germany, Poland, Congo, Philippines, and Louisiana.30) His team concluded that “while there is significantly more diversity in bacterial genera compared from different individuals than from the same individual, the diversity among individuals from the same location is nearly the same as the diversity among individuals from different locations.” The relative absence of variability between people in different regions implies that those factors which are highly variable, including food intake, may play a smaller than expected role in determining what at least a person's oral microbiota is. The Human Microbiome Research consortium concluded in 2012 that much of the diversity in healthy subjects remains unexplained.31)
  • Many bacteria cannot be cultured using traditional cultivation techniques – Using PCR, Fierer's team found that the hands of student subjects contained 332,000 genetically distinct bacteria belonging to 4,742 different species. 45% of the species detected were considered rare. This marked a hundred-fold increase in the number of bacterial species detected in previous studies that had relied on purely culture-based methods (such as the Petri dish) to characterize the human hand microbiota.32) These conclusions are supported by the aformentioned study of NASA clean rooms, which found that only 0.1 to 55% of viable cells found via PCR were able to grow on defined culture medium.33)
  • Some microbes need very few genes to persist – The genome of the microsporidia Encephalitozoon cuniculi (a pathogen which infects rabbits) is widely recognized as a model for extreme reduction and compaction. At only 2.9 Mbp, the genome encodes approximately 2,000 densely packed genes and little else. However, the nuclear genome of its sister, Encephalitozoon intestinalis, is even more reduced; at 2.3 Mbp, it represents a 20% reduction from an already severely compacted genome.34)
  • A number of bacteria never thought to exist in man, do, and in large numbers. – A 2007 study, for example, found hydrothermal vent eubacteria on a prosthetic hip joint, which represents fully 6% of the bacteria sequenced and analyzed.35) Hydrothermal vent eubacteria otherwise grow best above 176°F (80°C).
  • At least in fruit flies, gut microbes can alter mating preferences – In a 2010 study, mating preference was achieved by dividing a population of Drosophila melanogaster and rearing one part on a molasses medium and the other on a starch medium. When the isolated populations were mixed, “molasses flies” preferred to mate with other molasses flies and “starch flies” preferred to mate with other starch flies. The mating preference appeared after only one generation and was maintained for at least 37 generations. Antibiotic treatment abolished mating preference, suggesting that the fly microbiota was responsible for the phenomenon.36)
  • Bacteria practice altruism – In a 2010 Nature paper, James J. Collins and his colleagues exposed one culture of Escherichia coli—some strains of which colonize the human and animal gut; others of which are notorious for causing disease outbreaks—to increasing amounts of an antibiotic over time. When they periodically analyzed the levels of drug resistance in the colony, they saw something unexpected: although the entire population was thriving in the presence of the drug, only a few individual bacteria were actually resistant. Further analysis revealed that the resistant mutants were secreting a molecule called indole that thwarts their own growth but helps the rest of the population survive by activating drug-export pumps on the bacterial cell membranes.37)

Forms of bacteria

Nobody can pretend to know the complete life cycle and all the varieties of even a single bacterial species. It would be an assumption to think so.

Ernst Almquist, a colleague of Louis Pasteur

Free-floating (planktonic) bacteria may be consistent with the popular conception of bacteria in the human body, but these types of bacteria are in the minority.38) Bacteria are distinguished by nothing if not their diversity – diversity in form, size, and habitat. Indeed, bacteria can float in the bloodstream, but they can also live inside human cells. They can exist in communities known as biofilm A structured community of microorganisms encapsulated within a self-developed protective matrix and living together.. One form of bacteria that has been studied for decades and about which a lot is known is the L-formDifficult-to-culture bacteria that lack a cell wall and are not detectable by traditional culturing processes. Sometimes referred to as cell wall deficient bacteria..

Bacteria regularly engage in “shape shifting” between forms. For example, Paenibacillus dendritiformis bacteria survive overcrowding by switching between two distinct vegetative phenotypes.39)

L-form bacteria

Main article: L-form bacteria

As a part of their natural life cycle, bacteria can transform into a variety of forms. One of those phases is the L-form.

L-form bacteriaDifficult-to-culture bacteria that lack a cell wall and are not detectable by traditional culturing processes. Sometimes referred to as cell wall deficient bacteria., also known as cell wall deficient bacteria, are a phase of bacteria that are very small and lack cell walls.

Though the subject of a great deal of research over the last 100 years and implicated in a variety of diseases, L-forms remain largely misunderstood - or at the very least, underappreciated - by the medical research community. According to the Marshall Pathogenesis, L-forms are part of a metagenomic microbiotaThe community of bacterial pathogens including those in an intracellular and biofilm state which cause chronic disease. responsible for chronic disease.

→ Read more...

Biofilm bacteria

Main article: Biofilm bacteria

Biofilms are densely packed communities of microbial cells that grow on living or inert surfaces and surround themselves with secreted polymers. Many bacterial species form biofilms, and their study has revealed them to be complex and diverse. The structural and physiological complexity of biofilms has led to the idea that they are coordinated and cooperative groups, analogous to multicellular organisms.40)

Researchers have estimated that 60-80 percent of microbial infections in the body are caused by bacteria growing as a biofilm – as opposed to planktonic (free-floating) bacteria.

There is a perception that single-celled organisms are asocial, but that is misguided. When bacteria are under stress—which is the story of their lives—they team up and form this collective called a biofilm. If you look at naturally occurring biofilms, they have very complicated architecture. They are like cities with channels for nutrients to go in and waste to go out.

Andre Levchenko, PhD, Johns Hopkins University

Some external biofilm, namely chronic wounds and dental plaque, can be manually removed. Because of their inaccessibility and heightened resistance to certain antibiotic combinations and dosages, internal biofilm are more difficult to eradicate.

Biofilm bacteria are a part of what is known as the Th1 bacterial pathogens, which according to the Marshall Pathogenesis, collectively cause chronic disease. The Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. targets the Th1 pathogensThe community of bacterial pathogens which cause chronic inflammatory disease - one which almost certainly includes multiple species and bacterial forms., in part, through the use of pulsed low doses of antibiotics, because they limit the growth of “persister cells.”

Biofilm-related disease. 41)

→ Read more...

Other terms for very small bacteria

  • Mollicutes - A class of bacteria distinguished by the absence of a cell wall. Emil Wirostko et al. found mollicute-like organisms in eyes of patients with sarcoidosis and Crohn's.42) In a later study, Wirostko was more specific, finding “mycoplasma-like organisms,” using the term the term Mycoplasma to the best-known genus of Mollicutes.43)
  • Mycobacteria – A genus of Actinobacteria including tuberculosis and leprosy.
  • nanobacteria – A proposed class of cell-walled microorganisms with a size much smaller than the generally accepted lower limit size for life (about 200 nanometers for bacteria). The existence of nanobacteria as organisms is debated. Some researchers argue that nanobacteria are actually calcifying nanoparticles.

Effects of bacteria on their human host

The genomes and the respective proteomes of microbes in the body frequently interact with those expressed by their human hosts. This is a key part of what is know as the interactome. The “massive”44) co-occurrence of protein-coding genes between microbes and humans speaks to the survival advantage of such homology, and the extent to which sequence overlap may play a key role in disease. Indeed, manipulation of host cell fate and orchestrated choreography of inflammatory responses are recurrent themes in the strategies of microbial pathogens.45) Bacteria affect host-cell pathways and human gene expression through a number of increasingly well-documented ways.

<html><!–

Cell wall deficient bacteria in the immune cells of the eye. Higher levels of bacteria in the eye are thought to correspond to greater levels of photosensitivityAbnormal sensitivity to sunlight and bright lights. Also referred to as "sun flare" or "light flare.". This photo, taken by the Wirostkos, was made with an electron microscope.

–></html>

It is what bacteria do rather than what they are that commands attention, since our interest centers in the host rather than in the parasite.

Theobald Smith, M.D., circa 1904 46)

→ Read more...

2018 electron microscope study bacteria-in-your-brain

Successive infection and variability in disease

Chronic diseases manifest in patients and within patient populations with a high degree of variability. Some people have five chronic diseases, and others have one. Some patients experience symptoms of disease early in life while others not until they are very old. According to the Marshall Pathogenesis, this variability can be attributed to several factors.

Over the course of a lifetime, patients pick up the approximately 90 trillion bacteria to which they play host.47) While some researchers refer to each person's unique microbiota as an individual's “pathogen burden” and other terms,48) 49) we have referred to it as a person's “pea soupThe unique combination of bacterial pathogens (and co-mingling of bacterial genes) which accounts for each individual’s disease presentation..” In everyday language, the term pea soup is otherwise used to refer to a dense fog – an apt metaphor for the human microbiota. The promiscuity with which bacteria exchange DNA as well as the sheer number of bacteria to which any given person plays host are both factors which severely limit researchers' ability to accurately predict species-species and species-disease interactions.

The process by which a person accumulates the bacteria which drive disease is known as “successive infection.” In successive infection, an infectious cascade of pathogens slow the immune response and allow for subsequent infections to proliferate, resulting in dysbiosis (microbial imbalances). In patients sick with chronic inflammatory diseases, successive infection is ongoing and has additive properties: generally speaking, the more sick people are, the more sick they tend to become. Like a person's pea soup, the process by which a person accumulates additional bacteria via successive infection has an inherent variability to it.

→ Read more...

A prototypical example of evolution in eukaryotic organisms: Darwin's finches. Compared to what we now know about bacteria, finches engage in relatively little interspecies sharing of genetic material and are therefore easy to clearly define as individual species.

Reconsidering classifying bacteria as species

Traditionally, bacteria have been understood to:50) 51)

  • reproduce asexually
  • not recombine their genetic material with other bacterial species
  • be members of a clearly defined (or definable) species
  • for a single species, be largely clones of one another

Recent analyses of bacterial DNA have revealed that these assumptions are misplaced. To a much greater extent than ever anticipated, bacteria rapidly and frequently share their DNA with their fellow prokaryotes – even distantly related bacteria – through a process called horizontal gene transfer.52) Other processes such as homologous recombination further muddle any kind of genomic coherence.53) As a result the diversity and variability among bacteria are much greater than anticipated.

Given the rapid diversification in the microbial world, it has become increasingly difficult to classify bacteria with traditional approaches.54) 55) When it comes to bacteria, the very definition of “species” may have to be reconsidered.56)

There's no single such thing as a microbial species. There's too much diversity in the range of biological collections that we might call species. Recognizing the variability between different groups, we'll probably abandon the notion of there being a single cutoff in terms of species definition…. The species concept is doomed to radical irrelevance because we don't actually need it any more. Metagenomics will come in and shift the paradigm for it…. More [novel] organisms are created through [genetic] recombination than through mutation.

W. Ford Doolittle, PhD speaking at Metagenomics 2006

For example, Hanage of Imperial College of London concluded that the classification of certain isolates of Neisseria was inherently “fuzzy.”57)

Horizontal gene transferAny process in which a bacterium inserts genetic material into the genomes of other pathogens or into the genome of its host. can produce organisms effectively belonging to several species at once. Each circle represents an individual genome with the arrows representing the transfer of genetic material. The all-blue, all-gold and red/green circles represent genomes from three different bacterial groups that might be designated species. Source: Doolittle 2006

That said, there is some evidence that broad classifications of species appear more often in certain kinds of tissue:

  • The human gut seems to consist of large numbers of Firmicutes and Bacteroidetes.58)
  • Grice et al showed that there was greater diversity between different regions of the human skin in a single person than between similar skin regions of different people.59)

Study of metagenomics

If species are defined by a shared gene pool, phylogenetic trees (such as the kind used to describe how Darwin's finches have common ancestors) do not satisfactorily model the relationships among bacteria – not when one organism could be a member of two or more otherwise quite distinct “species” simultaneously.60) One commentator suggests the relationship between bacteria is actually more like that of a web.61)

Enter metagenomics - a field which transcends the search for individual genomes. Literally “beyond genomics”62), metagenomics is an approach which looks at how whole communities of bacteria develop and interact including biofilm bacteria, intracellular bacteria, and L-form bacteria. Metagenomics provides a way of understanding the mysterious majority of microbes, which have been historically difficult to culture and classify. It is an approach, which involves taking a sample from the environment, pooling the DNA from all the different species present, fracturing it into a mixture of relatively short fragments and then sequencing the lot.

Metagenomics has begun to provide valuable insights into which communities of microbes cause disease. Given that each gene codes for a protein and that a number of proteins have harmful effects, the presence of a particular gene can and has signalled the presence of a pathogenic form of bacteria.

Metagenomic communities may cause disease

For more than a century, researchers have confined their thinking to Koch's Postulates, which erroneously dictated that a given infectious disease is always caused by a single microbial species. Indeed, a small minority of diseases such as leprosy are caused by a single pathogen.

However, over the years, researchers have cataloged ample evidence of why certain chronic diseases appear to be caused by pathogens: the inflammationThe complex biological response of vascular tissues to harmful stimuli such as pathogens or damaged cells. It is a protective attempt by the organism to remove the injurious stimuli as well as initiate the healing process for the tissue., the granuloma, the typical co-infections, the unique non-pathological microbial communities, etc. But, rarely have researchers found evidence of a single infectious agent, and that is because chronic diseases aren't caused by an individual species of microbe, but by ever-evolving, patient-specific whole communities of microbes. A fully realized understanding of metagenomics offers this key insight into chronic disease pathology.

Molecular techniques have associated bacterial count in a pregnant woman's amniotic fluid to age at delivery. Pre-term birth is correlated with worse health outcomes for the newborn.

The genomic diversity and relative importance of distinct genotypes within natural bacterial populations have remained largely unknown and may remain so for years to come.63)

The Marshall PathogenesisA description for how chronic inflammatory diseases originate and develop. makes no claims about which individual microbial species, if there are such things, are to blame for chronic disease. Besides, such a consideration is ancillary. The unique and difficult to define mix of pathogens an individual has is known as his or her pea soup – one of the definitions of which is “a dense fog.”

Role of Vitamin D Receptor

At least some of the bacteria which cause disease are intracellular. These microbes take hold progressively through a process called successive infectionAn infectious cascade of pathogens in which initial infectious agents slow the immune response and make it easier for subsequent infections to proliferate.. Chronic forms of bacteria are able to survive and reproduce by generating substances which block and turn off the Vitamin D ReceptorA nuclear receptor located throughout the body that plays a key role in the innate immune response., a key nuclear receptorIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affects transcription. which controls the innate immune responseThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease.. So logical and powerful is this survival mechanism that it seems very likely that this is the primary mode by which chronic pathogenic forms persist. It simply makes evolutionary sense for pathogens to take full advantage of a receptor, which according to one recent study, transcribes hundreds of genes.64)

Acute infections

Main article: Acute infections

The white blood cell count rises in cases of infection, steroid use and other conditions.

The immune system responds to cues in the microenvironment to make acute and chronic adaptations in response to inflammation and injury. The therapeutic significance of adenosine-mediated effects on the immune system is discussed here. 65)

The term acute infection is used to refer to microbe living inside a host for a limited period of time, typically less than six months. However, an abundance of research has emerged suggesting that acute infections have long-lasting effects, predisposing a person to later onset of chronic diseases.

The purpose of the Marshall Protocol is to rehabilitate the immune response and improve the mix of microbes in the human body. In theory, this would free the immune response to target acute infections. Anecdotal reports from physicians and patients suggest that the MP is effective in this manner. To date, there have been no reports of tuberculosis or AIDS among MP patients.

→ Read more...

Learn more

===== Notes and comments =====

broken links clinical-and-public-health-microbiology – .

Nice bacteria finish last – resistant bacteria help their kin survive antibiotics, but at a cost

the link https://micronow.org/cohabiting-couples-have-similar-microbiomes/ will likely not function for very long after — 08.22.2017

PROBLEM LINK * Meet the Scientist #43 - Rob Knight: The Microbes That Inhabit Us – Knight studies our inner ecology: the 100 trillion microbes that grow in and on our bodies. Knight explained how hundreds of species can coexist on the palm of your hand, how bacteria manipulate your immune system and maybe even your brain, and how obesity and other health problems may come down to the wrong balance of microbes. leads to website micronow home, not Rob Knight's article

Hamilton, ON (August 31, 2011) - Scientists were surprised at how fast bacteria developed resistance to the miracle antibiotic drugs when they were developed less than a century ago. Now scientists at McMaster University have found that resistance has been around for at least 30,000 years.

Human skin harbours unknown bugs Staphylococcus aureus Staphylococcus bacteria are commonly found on the skin Human skin is a “virtual zoo” of bacteria, say researchers who have identified more than 200 species in samples taken from the forearm.

Study leader Professor Martin Blaser

17 November 2010 Life is found in deepest layer of Earth’s crust

By Michael Marshall

  • Legacy content
    • e79
    • e89

Update Fierer: Science. 2009 May 29;324(5931):1190-2. Topographical and temporal diversity of the human skin microbiome.

Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC; NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA.

Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda, MD 20892, USA.

Comment in:

  Science. 2009 Aug 21;325(5943):944-5. 

Abstract

Human skin is a large, heterogeneous organ that protects the body from pathogens while sustaining microorganisms that influence human health and disease. Our analysis of 16S ribosomal RNA gene sequences obtained from 20 distinct skin sites of healthy humans revealed that physiologically comparable sites harbor similar bacterial communities. The complexity and stability of the microbial community are dependent on the specific characteristics of the skin site. This topographical and temporal survey provides a baseline for studies that examine the role of bacterial communities in disease states and the microbial interdependencies required to maintain healthy skin.

PMID: 19478181

https://www.nature.com/news/2010/100714/full/news.2010.353.html

“microbiologists have discovered new viral genes in faeces. They find that the composition of virus populations inhabiting the tail ends of healthy intestines (as represented in our stools) is unique to each individual and stable over time. Even identical twins who share many of the same intestinal bacteria differed in their gut's viral make-up”

..Trevor..

BMC Genomics. 2010 Sep 7;11:488. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis.69)

Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, Li L, Nelson KE, Xia Y, Xiang C. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China. Abstract BACKGROUND: Bacterial vaginosis (BV) is an ecological disorder of the vaginal microbiota that affects millions of women annually, and is associated with numerous adverse health outcomes including pre-term birth and the acquisition of sexually transmitted infections. However, little is known about the overall structure and composition of vaginal microbial communities; most of the earlier studies focused on predominant vaginal bacteria in the process of BV. In the present study, the diversity and richness of vaginal microbiota in 50 BV positive and 50 healthy women from China were investigated using culture-independent PCR-denaturing gradient gel electrophoresis (DGGE) and barcoded 454 pyrosequencing methods, and validated by quantitative PCR. RESULTS: Our data demonstrated that there was a profound shift in the absolute and relative abundances of bacterial species present in the vagina when comparing populations associated with healthy and diseased conditions. In spite of significant interpersonal variations, the diversity of vaginal microbiota in the two groups could be clearly divided into two clusters. A total of 246,359 high quality pyrosequencing reads was obtained for evaluating bacterial diversity and 24,298 unique sequences represented all phylotypes. The most predominant phyla of bacteria identified in the vagina belonged to Firmicutes, Bacteroidetes, Actinobacteria and Fusobacteria. The higher number of phylotypes in BV positive women over healthy is consistent with the results of previous studies and a large number of low-abundance taxa which were missed in previous studies were revealed. Although no single bacterium could be identified as a specific marker for healthy over diseased conditions, three phyla - Bacteroidetes, Actinobacteria and Fusobacteria, and eight genera including Gardnerella, Atopobium, Megasphaera, Eggerthella, Aerococcus, Leptotrichia/Sneathia, Prevotella and Papillibacter were strongly associated with BV (p < 0.05). These genera are potentially excellent markers and could be used as targets for clinical BV diagnosis by molecular approaches. CONCLUSIONS: The data presented here have clearly profiled the overall structure of vaginal communities and clearly demonstrated that BV is associated with a dramatic increase in the taxonomic richness and diversity of vaginal microbiota. The study also provides the most comprehensive picture of the vaginal community structure and the bacterial ecosystem, and significantly contributes to the current understanding of the etiology of BV. PMID: 20819230

Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells70)

Infection of macrophages with mycobacteria has been shown to inhibit the macrophage response to IFN-gamma. In the current study, we examined the effect of Mycobacteria avium, Mycobacteria tuberculosis, and TLR2A receptor which is expressed on the surface of certain cells and recognizes native or foreign substances and passes on appropriate signals to the cell and/or the nervous system. stimulation on IFN-gamma-induced gene expression in human PMA-differentiated THP-1 monocytic cells. Mycobacterial infection inhibited IFN-gamma-induced expression of HLA-DRalpha and HLA-DRbeta mRNA and partially inhibited CIITA expression but did not affect expression of IFN regulatory factor-1 mRNA. To determine whether inhibition of histone deacetylase (HDAC) activity could rescue HLA-DR gene expression, butyric acid and MS-275, inhibitors of HDAC activity, were added at the time of M. avium or M. tuberculosis infection or TLR2 stimulation. HDAC inhibition restored the ability of these cells to express HLA-DRalpha and HLA-DRbeta mRNA in response to IFN-gamma. Histone acetylation induced by IFN-gamma at the HLA-DRalpha promoter was repressed upon mycobacteria infection or TLR2 stimulation. HDAC gene expression was not affected by mycobacterial infection. However, mycobacterial infection or TLR2 stimulation up-regulated expression of mammalian Sin3A, a corepressor that is required for MHC class II repression by HDAC. Furthermore, we show that the mammalian Sin3A corepressor is associated with the HLA-DRalpha promoter in M. avium-infected THP-1 cells stimulated with IFN-gamma. Thus, mycobacterial infection of human THP-1 cells specifically inhibits HLA-DR gene expression by a novel pathway that involves HDAC complex formation at the HLA-DR promoter, resulting in histone deacetylation and gene silencing.

Trevor? - “Crafty little buggers indeed! So what this is saying is that the mycobacteria are able to silence genes associated with the immune systems ability to react to infection by increasing HDAC. The use of HDAC inhibitors in culture lead to the clearance of recalcitrant intracellular bacterial infections. However, the use of HDAC inhibitors can lead to viremia as the body also uses HDAC to silence cellular machinary associated with viral replication as the HDAC inhibitors are non-specific in their action. Its a Catch22.”

Joyce,Good point. Helicobacter pylori were recently found circulating in peripheral blood, showing that the GI tract is not so well isolated from the rest of the body as had previously been believed.

I think the gut flora is key to introduction of new species to our systemic intraphagocytic microbiota over time, and also to how much of the innate immune system is occupied keeping the 'nasties' at bay in the GI tract.

The interesting thing is that although the MP abx profoundly change the gut flora, they do not wipe it out - as can be seen when discontinuing abx, the flora repopulates fairly quickly. I did once hear a presentation where it was claimed that a course of Cipro wiped out gut flora for a year. I don't believe that for a moment - the L-formsDifficult-to-culture bacteria that lack a cell wall and are not detectable by traditional culturing processes. Sometimes referred to as cell wall deficient bacteria. (like Hp) are clever little beasties…

..Trevor..

EXTREME PLEOMORPHISM AND THE BACTERIAL LIFE CYCLE: A FORGOTTEN CONTROVERSY

Science. 2009 Dec 18;326(5960):1694-7. Epub 2009 Nov 5.

Bacterial community variation in human body habitats across space and time.

Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA. Abstract Elucidating the biogeography of bacterial communities on the human body is critical for establishing healthy baselines from which to detect differences associated with diseases. To obtain an integrated view of the spatial and temporal distribution of the human microbiota, we surveyed bacteria from up to 27 sites in seven to nine healthy adults on four occasions. We found that community composition was determined primarily by body habitat. Within habitats, interpersonal variability was high, whereas individuals exhibited minimal temporal variability. Several skin locations harbored more diverse communities than the gut and mouth, and skin locations differed in their community assembly patterns. These results indicate that our microbiota, although personalized, varies systematically across body habitats and time; such trends may ultimately reveal how microbiome changes cause or prevent disease.

PMID: 19892944

From genomics to proteomics.

Tyers M, Mann M. Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Canada M5G 1×5. tyers@mshri.on.ca Abstract Proteomics is the study of the function of all expressed proteins. Tremendous progress has been made in the past few years in generating large-scale data sets for protein-protein interactions, organelle composition, protein activity patterns and protein profiles in cancer patients. But further technological improvements, organization of international proteomics projects and open access to results are needed for proteomics to fulfil its potential.

71)

A total of 14,000 physical interactions obtained from the GRID database were represented with the Osprey network visualization system (see https://biodata.mshri.on.ca/grid). Each edge in the graph represents an interaction between nodes, which are coloured according to Gene Ontology (GO) functional annotation. Highly connected complexes within the data set, shown at the perimeter of the central mass, are built from nodes that share at least three interactions within other complex members. The complete graph contains 4,543 nodes of 6,000 proteins encoded by the yeast genome, 12,843 interactions and an average connectivity of 2.82 per node. The 20 highly connected complexes contain 340 genes, 1,835 connections and an average connectivity of 5.39.

We still don't understand what a very large proportion of our DNA actually does. Sure, we understand how the genes work, but genes make up far less than half the total size of a the human genome. The non-gene, 'non-coding', regions are loosely termed “Junk DNA.”

Well, a group at Oxford has started to hone in on one likely function: to perpetuate components of the Human Microbiome. Here is a simplified version of their hypothesis:

https://www.tgdaily.com/general-sciences-features/52610-all-viruses-may-be-stowaways-within-our-dna

And the more complex concepts are in two papers at PLOS. First, a commentary:

https://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1001210

and then the actual paper:

https://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1001191

This is an important concept, which I have touched upon a few times, but generally felt it too complex to explain in detail. Now this paper, and the two commentaries above, can help me communicate the concept

..Trevor..

https://blogs.nature.com/news/thegreatbeyond/2010/11/viruses_tk.html

https://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1001191

It’s time for animals - including humans - to admit that the bacteria, viruses and other microbes have won. Our bodies are home to many times more bacterial cells than animal cells and countless trillions of viruses. Ancient retroviruses make up a good size chunk of our genome. Now, scientists have discovered that most any virus can set up shop in an animal's genomes and lay dormant for millions of years.

Mucosal Immunology (2011) 4, 133–138; doi:10.1038/mi.2010.89; published online 19 January 2011

A complex relationship: the interaction among symbiotic microbes, invading pathogens, and their mammalian host

M M Curtis1 and V Sperandio1

1Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Correspondence: V Sperandio, (Vanessa.Sperandio@utsouthwestern.edu)

Received 1 October 2010; Accepted 13 December 2010; Published online 19 January 2011.

Topof page Abstract Symbiosis between microbes and their mammalian host is vital to maintaining homeostasis. Symbiotic microbes within the gastrointestinal tract provide an array of benefits to the host, including promotion of host immunity. A coordinated effort of the host and symbiotic microbes deters the colonization and survival of many invading pathogens. However, pathogens have devised strategies to overcome these mechanisms. Furthermore, some pathogens can hijack host hormones and bacterial autoinducers to induce virulence traits. Intra- and inter-species (bacteria/bacteria) and interkingdom (bacteria/host) communication orchestrates the complex relationship among symbiotic microbes, invading pathogens, and their mammalian host. Insight into this communication will provide a foundation for the development of targeted antimicrobial therapies.

https://dx.doi.org/10.1371/journal.pbio.1001033

https://www.sciencedaily.com/releases/2011/03/110322172215.htm

Most bacteria harbor toxin–antitoxin (TA) systems, in which a bacterial toxin is rendered inactive under resting conditions by its antitoxin counterpart. Under conditions of stress, however, the antitoxin is degraded, freeing the toxin to attack its host bacterium. One such TA system, PezAT, has been difficult to study in the past because the PezT toxin is so toxic without its antitoxin counterpart that bacteria die before any useful measurements can be made. Here, we use a truncated version of PezT that kills bacteria more slowly than normal, allowing us to examine the mechanisms of how this TA system operates. We find that zeta toxins convert an essential building block of bacterial cell walls (known as UNAG) into a form that prevents normal cell wall growth, causing distortions in bacterial shape that leave the bacteria vulnerable to the hydrostatic pressure of its contents. Consequently, the bacteria burst, similar to what happens when they are treated with penicillin. These results may serve useful for designing new antibiotics. Additionally, our results support the hypothesis that activation of PezT during bacterial infections may be a method by which rapidly growing bacteria can instigate a suicide program, which would promote the release of virulence factors that facilitate spread of infections.

Differential Attraction of Malaria Mosquitoes to Volatile Blends Produced by Human Skin Bacteria

Were we but able to explain
The fiefdom of the microbe—
Why one man is his serf,
Another is his lord
When all are his domain….

C.B.H, Mandell: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Viruses that Infect Parasites that Infect Us: The Matryoshka Dolls of Human Pathogens

submitted by Chris Condayan on July 11, 2011 Tags: parasites, STC, viruses Source: schaechter.asmblog.org “We’re all too familiar with the viruses that can infect us, from the common cold to yellow fever virus to the endogenous retroviruses that make up a chunk of our genome. Many of us are also acquainted with parasites, such as tape worms or Giardia, that like to set up camp in the human body. But the world of parasites and viruses does not end there. Many parasites or endosymbionts can be infected with viruses. A classic example is Paramecium, which can harbor an endosymbiotic bacterium, Caedibacter, which in turn carries phages involved in making a toxin. But from the human point of view, things start to get particularly interesting when we consider the viruses that infect parasites of humans and how those viral infections—inside of a parasite inside of a person, somewhat like a Matryoshka nesting doll—may modulate the parasite’s interaction with its human host.”

BROKEN LINKS

?? * Microorganisms that inhabit our bodies could trigger some diseases - According to Dr. Marc Ouellette, scientific director of Canadian Institutes of Health Research's Institute of Infection and Immunity, “We're starting to realize that there are many, many possibilities or linkages between our microbiome and disease that we would not have expected before, especially complex diseases. This is really an emerging field where we think there are a lot of new discoveries to make that will have a direct impact in health.”

  • Bacteria ‘R’ Us – Feature article in the popular magazine Miller-McCune describes how bacteria have powers to engineer the environment, to communicate and to affect human well-being. They may even think.

===== References =====

1) , 11) , 47)
Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007 Oct 18;449(7164):804-10. doi: 10.1038/nature06244.
[PMID: 17943116] [PMCID: 3709439] [DOI: 10.1038/nature06244]
2)
Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, Rizzo C, Colonna-Romano G, Lio D, Di Carlo D, Palmas MG, Scurti M, Pini E, Franceschi C, Vasto S. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des. 2010;16(6):609-18. doi: 10.2174/138161210790883840.
[PMID: 20388071] [DOI: 10.2174/138161210790883840]
3)
Proal AD, Lindseth IA, Marshall TG. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes. Discov Med. 2017 Jan;23(124):51-60.
[PMID: 28245427]
4)
Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6578-83. doi: 10.1073/pnas.95.12.6578.
[PMID: 9618454] [PMCID: 33863] [DOI: 10.1073/pnas.95.12.6578]
5)
Moissl C, Osman S, La Duc MT, Dekas A, Brodie E, DeSantis T, Venkateswaran K. Molecular bacterial community analysis of clean rooms where spacecraft are assembled. FEMS Microbiol Ecol. 2007 Sep;61(3):509-21. doi: 10.1111/j.1574-6941.2007.00360.x. Epub 2007 Jul 26.
[PMID: 17655710] [DOI: 10.1111/j.1574-6941.2007.00360.x]
6)
Gao Z, Tseng C, Pei Z, Blaser MJ. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2927-32. doi: 10.1073/pnas.0607077104. Epub 2007 Feb 9.
[PMID: 17293459] [PMCID: 1815283] [DOI: 10.1073/pnas.0607077104]
7)
Björkstén B. The gut microbiota: a complex ecosystem. Clin Exp Allergy. 2006 Oct;36(10):1215-7. doi: 10.1111/j.1365-2222.2006.02579.x.
[PMID: 17014427] [DOI: 10.1111/j.1365-2222.2006.02579.x]
8)
Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol. 2008 Jan;24(1):4-10. doi: 10.1097/MOG.0b013e3282f2b0e8.
[PMID: 18043225] [DOI: 10.1097/MOG.0b013e3282f2b0e8]
9)
Yang X, Xie L, Li Y, Wei C. More than 9,000,000 unique genes in human gut bacterial community: estimating gene numbers inside a human body. PLoS One. 2009 Jun 29;4(6):e6074. doi: 10.1371/journal.pone.0006074.
[PMID: 19562079] [PMCID: 2699651] [DOI: 10.1371/journal.pone.0006074]
10)
Mullard A. Microbiology: the inside story. Nature. 2008 May 29;453(7195):578-80. doi: 10.1038/453578a.
[PMID: 18509412] [DOI: 10.1038/453578a]
12)
Marcy Y, Ouverney C, Bik EM, Lösekann T, Ivanova N, Martin HG, Szeto E, Platt D, Hugenholtz P, Relman DA, Quake SR. Dissecting biological "dark matter" with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):11889-94. doi: 10.1073/pnas.0704662104. Epub 2007 Jul 9.
[PMID: 17620602] [PMCID: 1924555] [DOI: 10.1073/pnas.0704662104]
13) , 14)
Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature. 2002 May 30;417(6888):552-5. doi: 10.1038/417552a.
[PMID: 12037568] [DOI: 10.1038/417552a]
15)
Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science. 2006 Jun 2;312(5778):1355-9. doi: 10.1126/science.1124234.
[PMID: 16741115] [PMCID: 3027896] [DOI: 10.1126/science.1124234]
16) , 33)
La Duc MT, Dekas A, Osman S, Moissl C, Newcombe D, Venkateswaran K. Isolation and characterization of bacteria capable of tolerating the extreme conditions of clean room environments. Appl Environ Microbiol. 2007 Apr;73(8):2600-11. doi: 10.1128/AEM.03007-06. Epub 2007 Feb 16.
[PMID: 17308177] [PMCID: 1855582] [DOI: 10.1128/AEM.03007-06]
17)
Miteva VI, Brenchley JE. Detection and isolation of ultrasmall microorganisms from a 120,000-year-old Greenland glacier ice core. Appl Environ Microbiol. 2005 Dec;71(12):7806-18. doi: 10.1128/AEM.71.12.7806-7818.2005.
[PMID: 16332755] [PMCID: 1317422] [DOI: 10.1128/AEM.71.12.7806-7818.2005]
18)
Mason OU, Nakagawa T, Rosner M, Van Nostrand JD, Zhou J, Maruyama A, Fisk MR, Giovannoni SJ. First investigation of the microbiology of the deepest layer of ocean crust. PLoS One. 2010 Nov 5;5(11):e15399. doi: 10.1371/journal.pone.0015399.
[PMID: 21079766] [PMCID: 2974637] [DOI: 10.1371/journal.pone.0015399]
19)
Nikkari S, McLaughlin IJ, Bi W, Dodge DE, Relman DA. Does blood of healthy subjects contain bacterial ribosomal DNA?. J Clin Microbiol. 2001 May;39(5):1956-9. doi: 10.1128/JCM.39.5.1956-1959.2001.
[PMID: 11326021] [PMCID: 88056] [DOI: 10.1128/JCM.39.5.1956-1959.2001]
20)
D'Costa VM, King CE, Kalan L, Morar M, Sung WWL, Schwarz C, Froese D, Zazula G, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD. Antibiotic resistance is ancient. Nature. 2011 Aug 31;477(7365):457-61. doi: 10.1038/nature10388.
[PMID: 21881561] [DOI: 10.1038/nature10388]
21) , 32)
Fierer N, Hamady M, Lauber CL, Knight R. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17994-9. doi: 10.1073/pnas.0807920105. Epub 2008 Nov 12.
[PMID: 19004758] [PMCID: 2584711] [DOI: 10.1073/pnas.0807920105]
22)
Wirth T, Wang X, Linz B, Novick RP, Lum JK, Blaser M, Morelli G, Falush D, Achtman M. Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4746-51. doi: 10.1073/pnas.0306629101. Epub 2004 Mar 29.
[PMID: 15051885] [PMCID: 387319] [DOI: 10.1073/pnas.0306629101]
23)
Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011 Feb;127(2):372-381.e1-3. doi: 10.1016/j.jaci.2010.10.048. Epub 2010 Dec 30.
[PMID: 21194740] [PMCID: 3037020] [DOI: 10.1016/j.jaci.2010.10.048]
24)
Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol. 2008 Aug;74(15):4898-909. doi: 10.1128/AEM.02884-07. Epub 2008 May 16.
[PMID: 18487399] [PMCID: 2519371] [DOI: 10.1128/AEM.02884-07]
25)
Enck P, Zimmermann K, Rusch K, Schwiertz A, Klosterhalfen S, Frick J. The effects of ageing on the colonic bacterial microflora in adults. Z Gastroenterol. 2009 Jul;47(7):653-8. doi: 10.1055/s-0028-1109055. Epub 2009 Jul 15.
[PMID: 19606407] [DOI: 10.1055/s-0028-1109055]
26)
Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006 Feb;55(2):205-11. doi: 10.1136/gut.2005.073817. Epub 2005 Sep 27.
[PMID: 16188921] [PMCID: 1856500] [DOI: 10.1136/gut.2005.073817]
27)
Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011 Jan;5(1):82-91. doi: 10.1038/ismej.2010.92. Epub 2010 Jul 8.
[PMID: 20613793] [PMCID: 3105672] [DOI: 10.1038/ismej.2010.92]
28)
Broxmeyer L, Cantwell A. AIDS: "it's the bacteria, stupid!". Med Hypotheses. 2008 Nov;71(5):741-8. doi: 10.1016/j.mehy.2008.06.012. Epub 2008 Aug 8.
[PMID: 18691828] [DOI: 10.1016/j.mehy.2008.06.012]
29)
Dumas M, Maibaum EC, Teague C, Ueshima H, Zhou B, Lindon JC, Nicholson JK, Stamler J, Elliott P, Chan Q, Holmes E. Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal Chem. 2006 Apr 1;78(7):2199-208. doi: 10.1021/ac0517085.
[PMID: 16579598] [PMCID: 6561113] [DOI: 10.1021/ac0517085]
30)
Nasidze I, Li J, Quinque D, Tang K, Stoneking M. Global diversity in the human salivary microbiome. Genome Res. 2009 Apr;19(4):636-43. doi: 10.1101/gr.084616.108. Epub 2009 Feb 27.
[PMID: 19251737] [PMCID: 2665782] [DOI: 10.1101/gr.084616.108]
31)
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012 Jun 13;486(7402):207-14. doi: 10.1038/nature11234.
[PMID: 22699609] [PMCID: 3564958] [DOI: 10.1038/nature11234]
34)
Corradi N, Pombert J, Farinelli L, Didier ES, Keeling PJ. The complete sequence of the smallest known nuclear genome from the microsporidian Encephalitozoon intestinalis. Nat Commun. 2010 Sep 21;1:77. doi: 10.1038/ncomms1082.
[PMID: 20865802] [PMCID: 4355639] [DOI: 10.1038/ncomms1082]
35)
Dempsey KE, Riggio MP, Lennon A, Hannah VE, Ramage G, Allan D, Bagg J. Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture. Arthritis Res Ther. 2007;9(3):R46. doi: 10.1186/ar2201.
[PMID: 17501992] [PMCID: 2206354] [DOI: 10.1186/ar2201]
36)
Sharon G, Segal D, Ringo JM, Hefetz A, Zilber-Rosenberg I, Rosenberg E. Commensal bacteria play a role in mating preference of Drosophila melanogaster. Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20051-6. doi: 10.1073/pnas.1009906107. Epub 2010 Nov 1.
[PMID: 21041648] [PMCID: 2993361] [DOI: 10.1073/pnas.1009906107]
37)
Lee HH, Molla MN, Cantor CR, Collins JJ. Bacterial charity work leads to population-wide resistance. Nature. 2010 Sep 2;467(7311):82-5. doi: 10.1038/nature09354.
[PMID: 20811456] [PMCID: 2936489] [DOI: 10.1038/nature09354]
38)
Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001 Apr;45(4):999-1007. doi: 10.1128/AAC.45.4.999-1007.2001.
[PMID: 11257008] [PMCID: 90417] [DOI: 10.1128/AAC.45.4.999-1007.2001]
39)
Be'er A, Florin E, Fisher CR, Swinney HL, Payne SM. Surviving bacterial sibling rivalry: inducible and reversible phenotypic switching in Paenibacillus dendritiformis. mBio. 2011 May 31;2(3):e00069-11. doi: 10.1128/mBio.00069-11. Print 2011.
[PMID: 21628502] [PMCID: 3104493] [DOI: 10.1128/mBio.00069-11]
40)
Nadell CD, Xavier JB, Foster KR. The sociobiology of biofilms. FEMS Microbiol Rev. 2009 Jan;33(1):206-24. doi: 10.1111/j.1574-6976.2008.00150.x. Epub 2008 Dec 3.
[PMID: 19067751] [DOI: 10.1111/j.1574-6976.2008.00150.x]
41)
Del Pozo JL. Biofilm-related disease. Expert Rev Anti Infect Ther. 2018 Jan;16(1):51-65. doi: 10.1080/14787210.2018.1417036. Epub 2017 Dec 19.
[PMID: 29235402] [DOI: 10.1080/14787210.2018.1417036]
42)
Wirostko E, Johnson L, Wirostko B. Sarcoidosis associated uveitis. Parasitization of vitreous leucocytes by mollicute-like organisms. Acta Ophthalmol (Copenh). 1989 Aug;67(4):415-24. doi: 10.1111/j.1755-3768.1989.tb01626.x.
[PMID: 2801045] [DOI: 10.1111/j.1755-3768.1989.tb01626.x]
43)
Wirostko E, Johnson LA, Wirostko BM, Farris RL. Mycoplasma-like organisms and ophthalmic disease. Trans Am Ophthalmol Soc. 1993;91:85-94; discussion 95-8.
[PMID: 8140710] [PMCID: 1298461]
44)
Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. Peptides. 2008 Oct;29(10):1755-66. doi: 10.1016/j.peptides.2008.05.022. Epub 2008 Jun 5.
[PMID: 18582510] [PMCID: 7115663] [DOI: 10.1016/j.peptides.2008.05.022]
45)
Relman D.A. and Falkow S. (2010). A molecular perspective of microbial pathogenecity. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. G. L. Mandell, J. E. Bennett and R. Dolin. Philadelphia, PA, Churchill Livingstone/Elsevier. 7.
46)
Smith, Theobald. Some Problems in the Life-history of Pathogenic Microörganisms, Amer. Med., viii, pp. 711-718, 1904.
48)
Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1417-20. doi: 10.1161/01.atv.20.6.1417.
[PMID: 10845851] [DOI: 10.1161/01.atv.20.6.1417]
49)
Mitchell S.V. Elkind et al. "'Infectious Burden' – New Insights into Stroke Prevention." European Neurological Review, 2010;5(1):34–38.
50) , 54)
Gevers D, Cohan FM, Lawrence JG, Spratt BG, Coenye T, Feil EJ, Stackebrandt E, Van de Peer Y, Vandamme P, Thompson FL, Swings J. Opinion: Re-evaluating prokaryotic species. Nat Rev Microbiol. 2005 Sep;3(9):733-9. doi: 10.1038/nrmicro1236.
[PMID: 16138101] [DOI: 10.1038/nrmicro1236]
51)
Gogarten JP, Doolittle WF, Lawrence JG. Prokaryotic evolution in light of gene transfer. Mol Biol Evol. 2002 Dec;19(12):2226-38. doi: 10.1093/oxfordjournals.molbev.a004046.
[PMID: 12446813] [DOI: 10.1093/oxfordjournals.molbev.a004046]
52)
Fraser C, Hanage WP, Spratt BG. Recombination and the nature of bacterial speciation. Science. 2007 Jan 26;315(5811):476-80. doi: 10.1126/science.1127573.
[PMID: 17255503] [PMCID: 2220085] [DOI: 10.1126/science.1127573]
53)
Feil EJ, Spratt BG. Recombination and the population structures of bacterial pathogens. Annu Rev Microbiol. 2001;55:561-90. doi: 10.1146/annurev.micro.55.1.561.
[PMID: 11544367] [DOI: 10.1146/annurev.micro.55.1.561]
55) , 60)
Doolittle WF, Papke RT. Genomics and the bacterial species problem. Genome Biol. 2006;7(9):116. doi: 10.1186/gb-2006-7-9-116.
[PMID: 17020593] [PMCID: 1794555] [DOI: 10.1186/gb-2006-7-9-116]
56) , 57)
Hanage WP, Fraser C, Spratt BG. Fuzzy species among recombinogenic bacteria. BMC Biol. 2005 Mar 7;3:6. doi: 10.1186/1741-7007-3-6.
[PMID: 15752428] [PMCID: 554772] [DOI: 10.1186/1741-7007-3-6]
58)
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006 Dec 21;444(7122):1022-3. doi: 10.1038/4441022a.
[PMID: 17183309] [DOI: 10.1038/4441022a]
59)
Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, Blakesley RW, Wolfsberg TG, Turner ML, Segre JA, NISC Comparative Sequencing Program. A diversity profile of the human skin microbiota. Genome Res. 2008 Jul;18(7):1043-50. doi: 10.1101/gr.075549.107. Epub 2008 May 23.
[PMID: 18502944] [PMCID: 2493393] [DOI: 10.1101/gr.075549.107]
61)
Legault BA, Lopez-Lopez A, Alba-Casado JC, Doolittle WF, Bolhuis H, Rodriguez-Valera F, Papke RT. Environmental genomics of "Haloquadratum walsbyi" in a saltern crystallizer indicates a large pool of accessory genes in an otherwise coherent species. BMC Genomics. 2006 Jul 4;7:171. doi: 10.1186/1471-2164-7-171.
[PMID: 16820057] [PMCID: 1560387] [DOI: 10.1186/1471-2164-7-171]
62)
Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chem Biol. 1998 Oct;5(10):R245-9. doi: 10.1016/s1074-5521(98)90108-9.
[PMID: 9818143] [DOI: 10.1016/s1074-5521(98)90108-9]
63)
Thompson JR, Pacocha S, Pharino C, Klepac-Ceraj V, Hunt DE, Benoit J, Sarma-Rupavtarm R, Distel DL, Polz MF. Genotypic diversity within a natural coastal bacterioplankton population. Science. 2005 Feb 25;307(5713):1311-3. doi: 10.1126/science.1106028.
[PMID: 15731455] [DOI: 10.1126/science.1106028]
64)
Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton S, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010 Oct;20(10):1352-60. doi: 10.1101/gr.107920.110. Epub 2010 Aug 24.
[PMID: 20736230] [PMCID: 2945184] [DOI: 10.1101/gr.107920.110]
65)
Syntax error [pubmed plugin]
66)
Ben-Jacob E, Schultz D. Bacteria determine fate by playing dice with controlled odds. Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13197-8. doi: 10.1073/pnas.1008254107. Epub 2010 Jul 21.
[PMID: 20660309] [PMCID: 2922178] [DOI: 10.1073/pnas.1008254107]
67)
Davies J. Darwin and microbiomes. EMBO Rep. 2009 Aug;10(8):805. doi: 10.1038/embor.2009.166.
[PMID: 19648955] [PMCID: 2726666] [DOI: 10.1038/embor.2009.166]
68)
Sirota-Madi A, Olender T, Helman Y, Ingham C, Brainis I, Roth D, Hagi E, Brodsky L, Leshkowitz D, Galatenko V, Nikolaev V, Mugasimangalam RC, Bransburg-Zabary S, Gutnick DL, Lancet D, Ben-Jacob E. Genome sequence of the pattern forming Paenibacillus vortex bacterium reveals potential for thriving in complex environments. BMC Genomics. 2010 Dec 17;11:710. doi: 10.1186/1471-2164-11-710.
[PMID: 21167037] [PMCID: 3012674] [DOI: 10.1186/1471-2164-11-710]
69)
Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, Li L, Nelson KE, Xia Y, Xiang C. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics. 2010 Sep 7;11:488. doi: 10.1186/1471-2164-11-488.
[PMID: 20819230] [PMCID: 2996984] [DOI: 10.1186/1471-2164-11-488]
70)
Wang Y, Curry HM, Zwilling BS, Lafuse WP. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J Immunol. 2005 May 1;174(9):5687-94. doi: 10.4049/jimmunol.174.9.5687.
[PMID: 15843570] [DOI: 10.4049/jimmunol.174.9.5687]
71)
Tyers M, Mann M. From genomics to proteomics. Nature. 2003 Mar 13;422(6928):193-7. doi: 10.1038/nature01510.
[PMID: 12634792] [DOI: 10.1038/nature01510]
home/pathogenesis/microbiota.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.